Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Fulvestrant at 10 mg/kg does not promote hair regrowth in dogs with alopecia X.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

The document concludes that managing PCOS involves lifestyle changes, medication for symptoms, and weight loss for fertility improvement.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

A systematic approach is crucial for managing hair loss in women.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

AGA can occur in children with family history; early diagnosis and treatment important.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.